Table 7.

Summary results for the in silico analyses

		Modelling for all test cases			Modelling for failures only
Missing baseline data	Model name	Effective alternatives predicted (%)		Superior alternatives predicted (%)	Effective alternatives predicted (%)		Superior alternatives predicted (%)
		S	R	S	S	R	S
Classifier models: response defined as follow-up plasma viral load of <50 copies/mL HIV RNA
None	CG	91	77	98	87	68	100
Genotype	CNG	94	80	100	91	71	100
Time on therapy	CG(−ToT)	91	76	99	86	65	100
Genotype/time on therapy	CNG(−ToT)	98	84	100	96	77	100
Genotype/CD4 count	CNG(−CD4)	95	84	99	91	77	100
Genotype/time on therapy/CD4 count	CNG(−ToT −CD4)	98	86	100	97	79	100
Absolute models: response defined as follow-up plasma viral load of <400 copies/mL HIV RNA
None	AG	92	84	96	85	73	100
Genotype	ANG	95	82	98	91	67	100
Time on therapy	AG(−ToT)a	93	86	97	85	74	100
Genotype/time on therapy	ANG(−ToT)a	100	96	98	99	92	100
Genotype/CD4 count	ANG(−CD4)	96	88	99	92	78	100
Genotype/time on therapy/CD4 count	ANG(−ToT −CD4)	97	90	98	95	81	100

S, standard drug list; R, restricted drug list.

^aPreviously published.¹⁵